Uncategorized

Verge, following trial failure, rebrands its AI drug discovery ambitions

Published

on

Formerly known as Verge Genomics, the new Verge Labs will help pharma and biotech partners match potential brain drugs to patients who best benefit from them.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version